What is the primary business model difference between Houlihan Lokey and Unum?

Houlihan Lokey operates primarily as an advisory and restructuring specialist, earning fees from M&A and financial restructuring activity. Unum, by contrast, is an insurance company focused on underwriting group policies and managing risk pools. The contrast highlights a services-driven fee model versus an underwriting-driven insurance model with exposure to claims and volatility in mortality and morbidity.

How should you interpret ‘record revenues’ for Houlihan Lokey?

Record revenues indicate the firm achieved its highest revenue level in the cited period, driven by advisory and restructuring demand. This reflects operating leverage from transaction volumes and market conditions, but also implies sensitivity to macro cycles. Investors should weigh this against volatility in future deal activity and cyclicality inherent to the advisory business.

What does a diversified insurance portfolio mean for Unum’s stability?

A diversified portfolio implies revenue and earnings come from multiple insurance lines, aiding resilience when one segment underperforms. For Unum, stable cash flows arise from ongoing premiums and risk pooling. However, underwriting results still hinge on claims experience and regulatory factors, potentially offsetting the diversification benefits during adverse events.

What does the price-to-earnings ratio tell you about Houlihan Lokey?

A P/E above 30 for Houlihan Lokey suggests investors expect higher future earnings growth or premium valuations for its advisory leadership. It can indicate optimism about long-term profitability, but also means the stock may be sensitive to rising discount rates or slower deal activity, potentially limiting upside during market downturns.

How should you view earnings quality for Unum?

Unum’s earnings quality benefits from disciplined underwriting and cost management, contributing to consistent profitability. While this supports a steady earnings stream, investors should assess volatility in claims experience and regulatory exposures that can create fluctuations in reported results over time.

What is the significance of return metrics like ROE and invested capital for Houlihan Lokey?

Healthy ROE and invested capital efficiency indicate Houlihan Lokey translates equity into profits effectively and allocates capital to generate returns. This supports a potentially attractive profitability profile, yet valuation sensitivity and cyclic deal activity remain key risks that could influence future performance.

What market forces affect both firms differently?

Houlihan Lokey is influenced by global M&A and restructuring cycles, while Unum is affected by morbidity/mortality trends and regulatory scrutiny in insurance. Despite different drivers, both operate in highly regulated environments where macroeconomic conditions, interest rates, and competitive dynamics can impact performance and outlook.

Why might Unum stock have underperformed broader indices recently?

Underperformance can reflect sector-specific concerns such as regulatory pressures, competitive dynamics, and the sensitivity of insurance earnings to claims experience. For Unum, the combination of these factors may dampen investor enthusiasm even when the business shows prudent underwriting and solid liquidity.

How should you compare these two stocks on a single-page?

Focus on business models, revenue drivers, and risk factors: Houlihan Lokey on advisory fees and cyclicality, Unum on underwriting results and claims exposure. Compare profitability metrics, balance sheet strength, and valuation in the context of each company’s sector, using the specific pros and cons provided to interpret potential strengths and weaknesses.

What should you consider about dividends when evaluating these stocks?

Houlihan Lokey offers a modest dividend yield around 1.2%, reflecting limited income relative to peers. Unum’s dividend considerations depend on policy distributions and capital management. In both cases, dividend yield should be weighed against growth prospects and payout stability within their respective sectors.

What is the value of a neutral comparison page like this?

A neutral comparison page presents business models, performance indicators, and market context without forecasts or recommendations. It helps readers understand how two different companies operate, what drives their finances, and how external factors may influence outcomes, enabling informed, independent analysis.

Houlihan Lokey vs Unum

Specialist global investment bank for mergers and restructuring vs US employee benefits and disability insurance provider. Which is the better buy for your portfolio in June 2026? Plain-English answer below.

Houlihan Lokey wins mandates advising on restructurings, M&A, and capital markets transactions as an independent investment bank, while Unum Group insures workers against disability, life events, and voluntary benefits through employer-sponsored plans. Both businesses generate revenue from corporate clients, but one profits most when deals flow and the other thrives on premium income that persists through economic cycles. Houlihan Lokey vs Unum examines revenue cyclicality, balance sheet risk, and which company's earnings stream justifies its current valuation.

Houlihan Lokey wins mandates advising on restructurings, M&A, and capital markets transactions as an independent investment bank, while Unum Group insures workers against disability, life events, and ...

Comparison Snapshot

Key Financial Metrics

HLI

Metric

UNM

$9.78B

Market Cap

$13.30B

48.64%

Potential Profit

9.49%

Hold

Analyst Rating

Buy

Discover More Comparisons

Houlihan Lokey vs CNA

Houlihan Lokey earns its fees advising on mergers, restructurings, and capital raises, with a business model that scales with deal activity but requires almost no balance sheet, while CNA Financial underwrites commercial insurance across middle-market and specialty segments. Both companies generate strong free cash flow in favorable environments and have rewarded shareholders with capital returns over time. Houlihan Lokey vs CNA unpacks how revenue predictability, operating leverage, and cycle sensitivity differ between a pure advisory franchise and a diversified commercial insurer.

Houlihan Lokey vs Franklin Templeton

Houlihan Lokey has carved out a leading position in restructuring advisory, thriving precisely when balance sheets break under debt loads, while Franklin Templeton manages trillions across mutual funds and ETFs for retail and institutional investors who need diversified market exposure. Both earn fees from capital-markets activity, but Houlihan Lokey gets busier when markets deteriorate and Franklin Templeton's AUM shrinks when they do. Houlihan Lokey vs Franklin Templeton explores how counter-cyclical advisory revenue competes with the economies of scale available to a massive traditional asset manager across a full market cycle.

Houlihan Lokey vs RGA

Houlihan Lokey is a top-ranked middle-market investment bank specializing in M&A advisory, restructuring, and financial opinions with a fee-for-service model that thrives in active deal markets, while RGA reinsures life and health insurance policies for carriers globally, earning spread income and mortality risk premiums over long policy horizons. Both companies profit from financial expertise applied to complex risks, just in very different timeframes and structures. Houlihan Lokey vs RGA reveals whether the transactional revenue engine of a leading advisory bank or the long-duration actuarial compounding of a life reinsurer builds more reliable wealth.

Investment Analysis

Houlihan Lokey

HLI

Pros

Houlihan Lokey achieved record fiscal year 2025 revenues of $2.39 billion, reflecting strong growth in advisory and restructuring services.
The firm maintains leading global market positions in M&A and financial restructuring, supported by consistent transaction volume leadership.
Adjusted diluted EPS rose to $6.29 in fiscal 2025, with healthy returns on equity and invested capital indicating efficient profitability.

Considerations

Earnings growth is highly sensitive to global M&A and restructuring cycles, exposing the business to macroeconomic volatility.
The company's valuation is elevated, with a price-to-earnings ratio above 30, which may limit upside in a rising rate environment.
Dividend yield remains modest at around 1.2%, offering limited income appeal compared to peers in the financial sector.

Unum

UNM

Pros

Unum Group maintains a diversified portfolio of group insurance products, providing stable cash flows across economic cycles.
The company has demonstrated disciplined underwriting and cost management, supporting consistent profitability in recent quarters.
Unum holds a strong balance sheet with solid liquidity and capital adequacy, enabling resilience in adverse market conditions.

Considerations

Revenue growth has been constrained by competitive pressures and regulatory scrutiny in the group insurance market.
The business faces ongoing exposure to morbidity and mortality risks, which can lead to volatility in claims experience.
Unum's stock has underperformed broader market indices over the past year, reflecting limited investor enthusiasm for the sector.

Related Market Insights

Banking Consolidation Europe: Might UniCredit Spark Wave?

UniCredit's Commerzbank stake sale could ignite a wave of European banking M&A. Discover investment opportunities in consolidation with Nemo's thematic Neme. Invest commission-free.